Concepedia

Publication | Open Access

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

DOIFull Paper Access

410

Citations

37

References

2017

Year

Michael F. Grunebaum, Hanga Galfalvy, Tse‐Hwei Choo, John G. Keilp, Vivek K. Moitra, Michelle S. Parris, Julia E. Marver, Ainsley K. Burke, Matthew S. Milak, M. Elizabeth Sublette,
American Journal of Psychiatry

Abstract

Adjunctive ketamine demonstrated a greater reduction in clinically significant suicidal ideation in depressed patients within 24 hours compared with midazolam, partially independently of antidepressant effect.

References

YearCitations

Page 1